Position in ALKS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$150,021
+$48,786 QoQ
Shares Held
2,863
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#311
of 421 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Smartleaf Asset Management LLC holds $2,809,974 across 43 Drug Manufacturers - Specialty & Generic names. ALKS ranks #8 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
14,573 | $493,733 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
28,454 | $456,117 | |
| 3 | ZTS |
Zoetis Inc.
|
5,136 | $369,072 | |
| 4 | HLN |
Haleon plc
|
33,747 | $314,859 | |
| 5 | VTRS |
Viatris Inc
|
14,592 | $231,720 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
4,084 | $193,050 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
341 | $184,764 | |
| 8 | ALKS |
Alkermes plc.
This page
|
2,863 | $150,021 |
All Filings in ALKS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $150,021 | 2,863 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $101,235 | 2,863 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $179,127 | 6,402 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $189,090 | 6,303 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $96,615 | 3,377 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $103,319 | 3,129 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $84,842 | 2,950 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $12,539 | 448 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,458 | 268 | Shares | Sole | 2024-10-08 | |
| No filing history on record for this holder in this stock. | ||||||